News
Now, all of this is just a metro ride away. The route of Metro 3 Phase 2a spans 18.6 km, starting from Dahisar and connecting to D N Nagar. This elevated corridor has 17 stations along the way.
But fortunately, it doesn't have to be. Here's a three-phase approach to help you narrow down your options for the right technology partner, not just a platform. Take a step back and look at where ...
Mumbai: The much-anticipated Phase 2 of Mumbai Metro Line 3 is nearing the finish line, with the 9.8-kilometre underground stretch from Bandra Kurla Complex (BKC) to Worli (Acharya Atre Chowk ...
A viral social media post claims a new 3-phase KVS recruitment process, but the Press Information Bureau has confirmed that it is fake. The Education Ministry has not approved any such change. A news ...
Qorvo 3-Phase BLDC Motor Driver Reduces Solution Size, Design Time and BOM Cost Qorvo, a global provider of connectivity and power solutions, has released the ACT72350—a 160V, 3-phase gate driver that ...
The second phase of Mumbai Metro Line 3, also known as the Aqua Line, is nearing its launch. The Commissioner of Metro Rail Safety (CMRS) began inspecting the 9.77-km underground stretch from Bandra ...
That's because it is already in the process of running the ongoing phase 3 LEVEL study and is set to begin the second phase 3 study soon in 2025. Both of these late-stage studies are using this ...
XYNGARI™ is the first once-weekly topical product candidate to demonstrate clinical benefit in a Phase 3 clinical trial for moderate-to-severe acne- - Over 30 million acne patients seek ...
Common Sense Oncology has developed principles designed to improve randomized phase 3 trials and ensure meaningful results. Recommendations address use of certain endpoints, toxicity reporting and ...
Bristol Myers (BMY) Squibb “announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos for the treatment of adult patients with symptomatic New York Heart Association class II-III non ...
Based on the phase 3 CABINET trial, the FDA approved Cabometyx for some patients with previously treated neuroendocrine tumors. The U.S. Food and Drug Administration (FDA) has approved Cabometyx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results